🇺🇸 FDA
Pipeline program

Self-hypnotic Relaxation

DAMD 17-01-1-0153

Phase 2 other completed

Quick answer

Self-hypnotic Relaxation for Breast Cancer is a Phase 2 program (other) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Breast Cancer
Phase
Phase 2
Modality
other
Status
completed

Clinical trials